Aeternum Health Inc. (AETN)

Aeternum Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2024	FY 2023	FY 2023
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Feb 29, 2024	Dec 31, 2023	Feb 28, 2023
Operating Revenue	0.04	0.2	0.07	0.02	0.02	0.02
Revenue	0.04	0.2	0.07	0.02	0.02	0.02
Revenue Growth (YoY)	-81.74%	212.73%	232.08%	-2.48%	-9.75%	-1.49%
Cost of Revenue	0.06	0.08	0.08	0.06	0.05	0.05
Gross Profit	-0.02	0.12	-0.01	-0.04	-0.03	-0.02
Selling, General & Admin	0.39	0.39	0.42	0.48	0.52	0.24
Operating Expenses	0.39	0.39	0.42	0.48	0.52	0.24
Operating Income	-0.41	-0.27	-0.43	-0.51	-0.55	-0.26
Interest Expense	-0.07	-0.07	-0.07	-0.08	-0.08	-0.01
Other Non Operating Income (Expenses)	-	-	0.05	0	-	0
EBT Excluding Unusual Items	-0.48	-0.34	-0.45	-0.59	-0.63	-0.27
Asset Writedown	-	-	-	-	-	-0.05
Other Unusual Items	-	-	-	-0.07	-	-
Pretax Income	-0.48	-0.34	-0.45	-0.66	-0.63	-0.32
Net Income	-0.48	-0.34	-0.45	-0.66	-0.63	-0.32
Net Income to Common	-0.48	-0.34	-0.45	-0.66	-0.63	-0.32
Shares Outstanding (Basic)	49	49	48	48	42	47
Shares Outstanding (Diluted)	49	49	48	48	42	47
Shares Change (YoY)	-1.07%	1.17%	0.71%	13.32%	-9.87%	-
EPS (Basic)	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01
EPS (Diluted)	-0.01	-0.01	-0.01	-0.01	-0.01	-0.01
Gross Margin	-41.87%	58.95%	-19.51%	-181.93%	-164.21%	-104.32%
Operating Margin	-997.52%	-132.22%	-661.06%	-2613.22%	-2746.84%	-1160.29%
Profit Margin	-1169.81%	-165.52%	-691.51%	-3375.65%	-3147.59%	-1416.11%
EBITDA	-	-	-	-0.51	-0.55	-0.25
D&A For EBITDA	-	-	-	0.01	0.01	0.01
EBIT	-0.41	-0.27	-0.43	-0.51	-0.55	-0.26
EBIT Margin	-	-132.22%	-	-	-	-
Revenue as Reported	0.04	0.2	0.07	0.02	0.02	0.02

Source: S&P Global Market Intelligence. Standard template. Financial Sources.